Navigation Links
Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
Date:3/11/2008

WESTFORD, Mass., March 11 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Tim Baker will present at the following institutional investor conferences in March:

-- On Monday, March 17, the Company will present at the Cowen and Company

28th Annual Health Care Conference, taking place at The Boston Marriott

Copley Place. The presentation will begin at 2:30 p.m. ET.

-- On Wednesday, March 19, Cynosure will present at the Citi Investment

Research 2008 Small and Mid-Cap Conference, taking place at the Four

Seasons at Mandalay Bay, Las Vegas. The presentation will begin at

1:45 p.m. ET.

These presentations will be available via live audio webcast and archived replay through the "Investor Relations" section of Cynosure's website, http://www.cynosure.com. To access the webcast, click on the link titled "Events."

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd: YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.

F
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
2. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
3. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
4. Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
5. Mentice AB Announces Leadership Changes Within Its Worldwide Operations
6. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
7. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
8. Lilly Announces Termination of AIR Insulin Program
9. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
10. Spectral announces 2007 financial results
11. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... MATEO, Calif., Nov. 24 ...cal company focused on developing and commercializ...ay that Anthony DiTonno, President and Chief Execu...Annual Piper Jaffray Health Care Conference, to be...tel in New York, New York. ,, Mr. DiTonno and ...
(Date:11/24/2009)... The FBI recently approved the Promega Power...ating in or generating DNA records for the Nationa...ison, WI USA (PRWEB) -- The FBI recently approved ...by laboratories participating in, or generating DN...). NDIS currently contains more than seven million...
(Date:11/24/2009)...BLIN, November 24 Shire ...lty biopharmaceutical company, today,announced tha... Agency for,velaglucerase alfa, the company,s enzy...tment of Type 1 Gaucher disease. This is the third... has been submitted, with previous,submissions in ...
(Date:11/24/2009)...,November24/PRNewswire/--HealthRoboticstodayannoun...oupofselected,investors.ThisrecentlyformedToronto-...Canada,Inc.andwillmarket,install,andsupport,Health...he,revolutionaryproductofferingsi.v.STATION(TM),i....lalsoprovideassistanceonan"asneeded,basis"toitsstr...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical com...unced,that it had received approval to market Arid...issmedic., Aridol is indicated for measuring airw...proved in 13 countries - Denmark, Finland, France,... Portugal, Spain, Sweden,Switzerland and the Unite...
... Bunge Limited,(NYSE: BG ), an integrated, global...results for the quarter ended September 30, 2008, ...opening., Bunge Limited,s management will host a ...008, to discuss the company,s results., To listen...1. If you,are located outside of the United States...
...NA2.0, the leading synthetic genomics company, ann...e, including a fresh, appealing new interface, a c...blished synthetic gene applications and a revamped...h a powerful resource for analyzing DNA and protei..., Calif. (PRWEB) October 17, 2008 -- DNA2.0, the l...
Other Biology Technology:Pharmaxis Aridol Approved for Sale in Switzerland 2Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call 2DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus 2
(Date:11/25/2009)... Larisch, Head of the Cell Death Research Laborato...ogy, has been awarded the prestigious Johnson & Jo...ring the cause of brain cell damage in Parkinson,s... scientists in support of innovation and excellenc...y conferred earlier this month at an event at the ...
(Date:11/24/2009)...ds of years it has been prescribed by traditional ...m headaches and stomach pain to fever and flu. , ...niversity have been able to scientifically prove t...otherwise known as Brazilian mint. , Testing this... by researcher Graciela Rocha was able to show tha...
(Date:11/24/2009)...level action of a remarkable class of ring-shaped ...ith the Lawrence Berkeley National Laboratory (Ber...llography beamline at the Advanced Light Source (A...ne expression and replication, and are vital to th...ectious agents, such as the human papillomavirus, ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Nationwide telemedicine networks are essential for successful health care reform 49432 1Nationwide telemedicine networks are essential for successful health care reform 49432 2McGill University receives almost 2463 million under CFI program to support five research projects 8910 1McGill University receives almost 2463 million under CFI program to support five research projects 8910 2McGill University receives almost 2463 million under CFI program to support five research projects 8910 3Is Your Teenager Using Prescription Drugs Behind Your Back 3F 0ATestCountry Drug Test Panel Numbers Tally with NIDA Fact Sheet Reports on Prescription 49431 1Is Your Teenager Using Prescription Drugs Behind Your Back 3F 0ATestCountry Drug Test Panel Numbers Tally with NIDA Fact Sheet Reports on Prescription 49431 2Is Your Teenager Using Prescription Drugs Behind Your Back 3F 0ATestCountry Drug Test Panel Numbers Tally with NIDA Fact Sheet Reports on Prescription 49431 3
...ity of Pittsburgh published in the Nov. 20 edition...he first stages of the evolution of separate sexes...oped from hermaphroditic ancestors. These early st...ority of animal species developed into the arguabl... for scientists to observe the transition. , Howe...
... Austin-based startup cofounded by Mauro Ferrari, ...enter at Houston (UTHSC-Houston), to improve the e...ations, has received a record $3.5 million Commerc...logy Fund (ETF). , NMS was one of six companies t...by Texas Gov. Rick Perry on Tuesday, Nov. 18. , T...
...an . , Halle/Saale. For the first time it is now... alien species are present in Europe, their impact.... More than 11,000 alien species have been documen...nventory for Europe), a unique three year research...unded by the European Union that provides new know...
Other Biology News:Two from one: Pitt research maps out evolution of genders from hermaphroditic ancestors 2Texas invests record $3.5 million in startup cofounded by UT's Mauro Ferrari 211,000 alien species invade Europe 2
...s generated from rabbits immunized with a KLH conj... of human PLAU. Purified rabbit polyclonal antibod...his antibody is purified through a protein G colum... and neutralized immediately after elution then fo...
...id polypeptide sequence corresponding to Tyr89 Gl...ion of a recombinant soluble proform of MT1-MMP pu...The specific activity of MT1-MMP catalytic domain ...rolyzes 1 mol peptide (7-methoxycoumarin-4-yl)acet...
...ht, high current power supply capable of producing...lent choice for PAGE, SDS-PAGE and DNA or RNA subm...troblotting applications.A dual function 100-hour ... automatically accrue elapsed time when operated i...
Anti-Interferon-beta (IFNb) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: